nodes	percent_of_prediction	percent_of_DWPC	metapath
Clevidipine—CYP2E1—prostate cancer	0.133	0.382	CbGaD
Clevidipine—CYP2C19—prostate cancer	0.132	0.378	CbGaD
Clevidipine—CYP3A4—prostate cancer	0.0838	0.24	CbGaD
Clevidipine—CYP2C19—Nilutamide—prostate cancer	0.0271	0.0612	CbGbCtD
Clevidipine—CYP2C19—Bicalutamide—prostate cancer	0.0271	0.0612	CbGbCtD
Clevidipine—CYP2E1—Estrone—prostate cancer	0.0259	0.0585	CbGbCtD
Clevidipine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.025	0.0563	CbGbCtD
Clevidipine—CYP2C9—Nilutamide—prostate cancer	0.0226	0.0509	CbGbCtD
Clevidipine—CYP2C9—Bicalutamide—prostate cancer	0.0226	0.0509	CbGbCtD
Clevidipine—CYP2C19—Flutamide—prostate cancer	0.0225	0.0507	CbGbCtD
Clevidipine—CYP1A2—Flutamide—prostate cancer	0.0207	0.0468	CbGbCtD
Clevidipine—CYP2D6—Bicalutamide—prostate cancer	0.0206	0.0465	CbGbCtD
Clevidipine—CYP2D6—Abiraterone—prostate cancer	0.0171	0.0385	CbGbCtD
Clevidipine—CYP2E1—Mitoxantrone—prostate cancer	0.0154	0.0348	CbGbCtD
Clevidipine—CYP1A2—Estrone—prostate cancer	0.015	0.0338	CbGbCtD
Clevidipine—CYP2C9—Estrone—prostate cancer	0.0135	0.0305	CbGbCtD
Clevidipine—CYP3A4—Bicalutamide—prostate cancer	0.0131	0.0296	CbGbCtD
Clevidipine—CYP3A4—Estramustine—prostate cancer	0.0122	0.0275	CbGbCtD
Clevidipine—CYP3A4—Abiraterone—prostate cancer	0.0109	0.0245	CbGbCtD
Clevidipine—CYP3A4—Flutamide—prostate cancer	0.0109	0.0245	CbGbCtD
Clevidipine—CYP2C9—Capecitabine—prostate cancer	0.0102	0.0231	CbGbCtD
Clevidipine—CYP1A2—Conjugated Estrogens—prostate cancer	0.00981	0.0221	CbGbCtD
Clevidipine—CYP2E1—Etoposide—prostate cancer	0.00972	0.0219	CbGbCtD
Clevidipine—CYP2C19—Estradiol—prostate cancer	0.00933	0.0211	CbGbCtD
Clevidipine—CYP1A2—Estradiol—prostate cancer	0.00861	0.0194	CbGbCtD
Clevidipine—CYP3A4—Cabazitaxel—prostate cancer	0.00804	0.0181	CbGbCtD
Clevidipine—CYP2C19—Prednisone—prostate cancer	0.00803	0.0181	CbGbCtD
Clevidipine—CYP3A4—Estrone—prostate cancer	0.00786	0.0177	CbGbCtD
Clevidipine—CYP2C9—Estradiol—prostate cancer	0.00776	0.0175	CbGbCtD
Clevidipine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.007	0.0158	CbGbCtD
Clevidipine—CYP1A2—Etoposide—prostate cancer	0.00562	0.0127	CbGbCtD
Clevidipine—CYP3A4—Conjugated Estrogens—prostate cancer	0.00514	0.0116	CbGbCtD
Clevidipine—CYP3A4—Mitoxantrone—prostate cancer	0.00467	0.0105	CbGbCtD
Clevidipine—CYP3A4—Estradiol—prostate cancer	0.00451	0.0102	CbGbCtD
Clevidipine—CYP3A4—Prednisone—prostate cancer	0.00388	0.00875	CbGbCtD
Clevidipine—Blood triglycerides increased—Abiraterone—prostate cancer	0.00338	0.0489	CcSEcCtD
Clevidipine—CYP2D6—Doxorubicin—prostate cancer	0.00316	0.00713	CbGbCtD
Clevidipine—CYP3A4—Etoposide—prostate cancer	0.00295	0.00665	CbGbCtD
Clevidipine—CYP3A4—Docetaxel—prostate cancer	0.0027	0.00608	CbGbCtD
Clevidipine—Ileus—Cabazitaxel—prostate cancer	0.00241	0.0348	CcSEcCtD
Clevidipine—CACNA1S—seminal vesicle—prostate cancer	0.0024	0.0989	CbGeAlD
Clevidipine—CYP2C19—urine—prostate cancer	0.00239	0.0987	CbGeAlD
Clevidipine—CYP3A4—Doxorubicin—prostate cancer	0.00201	0.00453	CbGbCtD
Clevidipine—CYP1A2—urine—prostate cancer	0.00196	0.0806	CbGeAlD
Clevidipine—CYP2C9—urine—prostate cancer	0.00186	0.0765	CbGeAlD
Clevidipine—CYP2E1—urine—prostate cancer	0.00176	0.0725	CbGeAlD
Clevidipine—CACNA1D—prostate gland—prostate cancer	0.00149	0.0614	CbGeAlD
Clevidipine—CYP3A4—urine—prostate cancer	0.00142	0.0583	CbGeAlD
Clevidipine—CYP2D6—urine—prostate cancer	0.00139	0.0574	CbGeAlD
Clevidipine—Atrial fibrillation—Degarelix—prostate cancer	0.00139	0.02	CcSEcCtD
Clevidipine—CACNA1C—prostate gland—prostate cancer	0.00138	0.0567	CbGeAlD
Clevidipine—Renal failure acute—Cabazitaxel—prostate cancer	0.00134	0.0194	CcSEcCtD
Clevidipine—Atrial fibrillation—Cabazitaxel—prostate cancer	0.00131	0.0189	CcSEcCtD
Clevidipine—Acute coronary syndrome—Estramustine—prostate cancer	0.00126	0.0182	CcSEcCtD
Clevidipine—Myocardial infarction—Estramustine—prostate cancer	0.00125	0.0181	CcSEcCtD
Clevidipine—Acute coronary syndrome—Abiraterone—prostate cancer	0.00122	0.0177	CcSEcCtD
Clevidipine—Myocardial infarction—Abiraterone—prostate cancer	0.00122	0.0176	CcSEcCtD
Clevidipine—Acute coronary syndrome—Estrone—prostate cancer	0.0012	0.0174	CcSEcCtD
Clevidipine—Myocardial infarction—Estrone—prostate cancer	0.0012	0.0173	CcSEcCtD
Clevidipine—Atrial fibrillation—Bicalutamide—prostate cancer	0.00112	0.0162	CcSEcCtD
Clevidipine—Acute coronary syndrome—Estradiol valerate/Dienogest—prostate cancer	0.00105	0.0152	CcSEcCtD
Clevidipine—Myocardial infarction—Estradiol valerate/Dienogest—prostate cancer	0.00104	0.0151	CcSEcCtD
Clevidipine—Acute coronary syndrome—Degarelix—prostate cancer	0.000998	0.0144	CcSEcCtD
Clevidipine—Myocardial infarction—Degarelix—prostate cancer	0.000993	0.0143	CcSEcCtD
Clevidipine—Acute coronary syndrome—Bicalutamide—prostate cancer	0.000807	0.0116	CcSEcCtD
Clevidipine—Myocardial infarction—Bicalutamide—prostate cancer	0.000802	0.0116	CcSEcCtD
Clevidipine—Renal failure acute—Conjugated Estrogens—prostate cancer	0.000792	0.0114	CcSEcCtD
Clevidipine—Blood triglycerides increased—Capecitabine—prostate cancer	0.000768	0.0111	CcSEcCtD
Clevidipine—BCHE—prostate gland—prostate cancer	0.000755	0.0311	CbGeAlD
Clevidipine—Ileus—Docetaxel—prostate cancer	0.000734	0.0106	CcSEcCtD
Clevidipine—Dyspnoea—Estramustine—prostate cancer	0.000726	0.0105	CcSEcCtD
Clevidipine—Ileus—Capecitabine—prostate cancer	0.000711	0.0103	CcSEcCtD
Clevidipine—Dyspnoea—Abiraterone—prostate cancer	0.000705	0.0102	CcSEcCtD
Clevidipine—Blood triglycerides increased—Prednisone—prostate cancer	0.000684	0.00987	CcSEcCtD
Clevidipine—Acute coronary syndrome—Ethinyl Estradiol—prostate cancer	0.000682	0.00984	CcSEcCtD
Clevidipine—Myocardial infarction—Ethinyl Estradiol—prostate cancer	0.000678	0.00979	CcSEcCtD
Clevidipine—CACNA1D—testis—prostate cancer	0.000657	0.0271	CbGeAlD
Clevidipine—Dyspnoea—Nilutamide—prostate cancer	0.000644	0.0093	CcSEcCtD
Clevidipine—BCHE—seminal vesicle—prostate cancer	0.000638	0.0263	CbGeAlD
Clevidipine—CYP2E1—prostate gland—prostate cancer	0.000631	0.026	CbGeAlD
Clevidipine—CACNA1C—testis—prostate cancer	0.000606	0.025	CbGeAlD
Clevidipine—Hypotension—Degarelix—prostate cancer	0.000603	0.00871	CcSEcCtD
Clevidipine—Tachycardia—Cabazitaxel—prostate cancer	0.000594	0.00857	CcSEcCtD
Clevidipine—Renal failure acute—Mitoxantrone—prostate cancer	0.000591	0.00853	CcSEcCtD
Clevidipine—Dyspnoea—Degarelix—prostate cancer	0.000576	0.00831	CcSEcCtD
Clevidipine—Hypotension—Cabazitaxel—prostate cancer	0.000568	0.00821	CcSEcCtD
Clevidipine—Acute coronary syndrome—Goserelin—prostate cancer	0.000561	0.0081	CcSEcCtD
Clevidipine—Myocardial infarction—Goserelin—prostate cancer	0.000558	0.00805	CcSEcCtD
Clevidipine—Acute coronary syndrome—Conjugated Estrogens—prostate cancer	0.000556	0.00802	CcSEcCtD
Clevidipine—Myocardial infarction—Conjugated Estrogens—prostate cancer	0.000553	0.00798	CcSEcCtD
Clevidipine—Dyspnoea—Cabazitaxel—prostate cancer	0.000542	0.00783	CcSEcCtD
Clevidipine—CYP2E1—seminal vesicle—prostate cancer	0.000534	0.022	CbGeAlD
Clevidipine—Vomiting—Estramustine—prostate cancer	0.000518	0.00748	CcSEcCtD
Clevidipine—Headache—Estramustine—prostate cancer	0.00051	0.00737	CcSEcCtD
Clevidipine—Vomiting—Abiraterone—prostate cancer	0.000503	0.00726	CcSEcCtD
Clevidipine—Hypersensitivity—Estradiol valerate/Dienogest—prostate cancer	0.0005	0.00722	CcSEcCtD
Clevidipine—Ileus—Epirubicin—prostate cancer	0.000495	0.00715	CcSEcCtD
Clevidipine—Vomiting—Estrone—prostate cancer	0.000495	0.00714	CcSEcCtD
Clevidipine—Headache—Estrone—prostate cancer	0.000488	0.00704	CcSEcCtD
Clevidipine—Nausea—Estramustine—prostate cancer	0.000484	0.00699	CcSEcCtD
Clevidipine—CYP1A2—renal system—prostate cancer	0.000478	0.0197	CbGeAlD
Clevidipine—CACNA1D—lymph node—prostate cancer	0.000476	0.0196	CbGeAlD
Clevidipine—Hypersensitivity—Degarelix—prostate cancer	0.000476	0.00687	CcSEcCtD
Clevidipine—Nimodipine—AHR—prostate cancer	0.000472	0.12	CrCbGaD
Clevidipine—Dyspnoea—Bicalutamide—prostate cancer	0.000465	0.00672	CcSEcCtD
Clevidipine—Nausea—Estrone—prostate cancer	0.000462	0.00667	CcSEcCtD
Clevidipine—Vomiting—Nilutamide—prostate cancer	0.00046	0.00664	CcSEcCtD
Clevidipine—Ileus—Doxorubicin—prostate cancer	0.000458	0.00661	CcSEcCtD
Clevidipine—Vomiting—Flutamide—prostate cancer	0.000458	0.00661	CcSEcCtD
Clevidipine—Headache—Nilutamide—prostate cancer	0.000453	0.00654	CcSEcCtD
Clevidipine—Headache—Flutamide—prostate cancer	0.000451	0.00651	CcSEcCtD
Clevidipine—Hypersensitivity—Cabazitaxel—prostate cancer	0.000448	0.00647	CcSEcCtD
Clevidipine—Acute coronary syndrome—Estradiol—prostate cancer	0.000445	0.00642	CcSEcCtD
Clevidipine—Myocardial infarction—Estradiol—prostate cancer	0.000442	0.00639	CcSEcCtD
Clevidipine—CACNA1C—lymph node—prostate cancer	0.000439	0.0181	CbGeAlD
Clevidipine—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.000432	0.00623	CcSEcCtD
Clevidipine—CYP2E1—renal system—prostate cancer	0.00043	0.0177	CbGeAlD
Clevidipine—Nausea—Nilutamide—prostate cancer	0.000429	0.0062	CcSEcCtD
Clevidipine—Nausea—Flutamide—prostate cancer	0.000427	0.00617	CcSEcCtD
Clevidipine—Headache—Estradiol valerate/Dienogest—prostate cancer	0.000426	0.00614	CcSEcCtD
Clevidipine—CYP2E1—urethra—prostate cancer	0.000423	0.0174	CbGeAlD
Clevidipine—Acute coronary syndrome—Mitoxantrone—prostate cancer	0.000414	0.00598	CcSEcCtD
Clevidipine—Myocardial infarction—Mitoxantrone—prostate cancer	0.000412	0.00595	CcSEcCtD
Clevidipine—Vomiting—Degarelix—prostate cancer	0.000411	0.00593	CcSEcCtD
Clevidipine—Headache—Degarelix—prostate cancer	0.000405	0.00584	CcSEcCtD
Clevidipine—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.000403	0.00582	CcSEcCtD
Clevidipine—Atrial fibrillation—Docetaxel—prostate cancer	0.000398	0.00575	CcSEcCtD
Clevidipine—Renal failure acute—Capecitabine—prostate cancer	0.000396	0.00571	CcSEcCtD
Clevidipine—BCHE—bone marrow—prostate cancer	0.000389	0.016	CbGeAlD
Clevidipine—Vomiting—Cabazitaxel—prostate cancer	0.000387	0.00558	CcSEcCtD
Clevidipine—Atrial fibrillation—Capecitabine—prostate cancer	0.000385	0.00556	CcSEcCtD
Clevidipine—Hypersensitivity—Bicalutamide—prostate cancer	0.000384	0.00555	CcSEcCtD
Clevidipine—Nausea—Degarelix—prostate cancer	0.000384	0.00554	CcSEcCtD
Clevidipine—Headache—Cabazitaxel—prostate cancer	0.000381	0.0055	CcSEcCtD
Clevidipine—Nausea—Cabazitaxel—prostate cancer	0.000361	0.00522	CcSEcCtD
Clevidipine—Tachycardia—Goserelin—prostate cancer	0.000354	0.00511	CcSEcCtD
Clevidipine—Tachycardia—Conjugated Estrogens—prostate cancer	0.000351	0.00507	CcSEcCtD
Clevidipine—CYP3A4—renal system—prostate cancer	0.000346	0.0143	CbGeAlD
Clevidipine—Acute coronary syndrome—Etoposide—prostate cancer	0.000345	0.00498	CcSEcCtD
Clevidipine—Myocardial infarction—Etoposide—prostate cancer	0.000343	0.00495	CcSEcCtD
Clevidipine—CYP2D6—renal system—prostate cancer	0.000341	0.014	CbGeAlD
Clevidipine—Hypotension—Goserelin—prostate cancer	0.000339	0.0049	CcSEcCtD
Clevidipine—Hypotension—Conjugated Estrogens—prostate cancer	0.000336	0.00485	CcSEcCtD
Clevidipine—BCHE—testis—prostate cancer	0.000332	0.0137	CbGeAlD
Clevidipine—Vomiting—Bicalutamide—prostate cancer	0.000332	0.00479	CcSEcCtD
Clevidipine—Headache—Bicalutamide—prostate cancer	0.000327	0.00472	CcSEcCtD
Clevidipine—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.000325	0.00469	CcSEcCtD
Clevidipine—Dyspnoea—Goserelin—prostate cancer	0.000324	0.00467	CcSEcCtD
Clevidipine—Dyspnoea—Conjugated Estrogens—prostate cancer	0.000321	0.00463	CcSEcCtD
Clevidipine—Nausea—Bicalutamide—prostate cancer	0.00031	0.00447	CcSEcCtD
Clevidipine—Acute coronary syndrome—Docetaxel—prostate cancer	0.000287	0.00414	CcSEcCtD
Clevidipine—Myocardial infarction—Docetaxel—prostate cancer	0.000285	0.00411	CcSEcCtD
Clevidipine—Tachycardia—Estradiol—prostate cancer	0.000281	0.00405	CcSEcCtD
Clevidipine—Vomiting—Ethinyl Estradiol—prostate cancer	0.00028	0.00405	CcSEcCtD
Clevidipine—CYP2E1—testis—prostate cancer	0.000278	0.0115	CbGeAlD
Clevidipine—Acute coronary syndrome—Capecitabine—prostate cancer	0.000277	0.004	CcSEcCtD
Clevidipine—Headache—Ethinyl Estradiol—prostate cancer	0.000276	0.00399	CcSEcCtD
Clevidipine—Myocardial infarction—Capecitabine—prostate cancer	0.000276	0.00398	CcSEcCtD
Clevidipine—Renal failure acute—Epirubicin—prostate cancer	0.000276	0.00398	CcSEcCtD
Clevidipine—Hypersensitivity—Goserelin—prostate cancer	0.000267	0.00386	CcSEcCtD
Clevidipine—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.000265	0.00382	CcSEcCtD
Clevidipine—Nausea—Ethinyl Estradiol—prostate cancer	0.000262	0.00378	CcSEcCtD
Clevidipine—Tachycardia—Mitoxantrone—prostate cancer	0.000262	0.00378	CcSEcCtD
Clevidipine—Dyspnoea—Estradiol—prostate cancer	0.000257	0.0037	CcSEcCtD
Clevidipine—Renal failure acute—Doxorubicin—prostate cancer	0.000255	0.00368	CcSEcCtD
Clevidipine—Hypotension—Mitoxantrone—prostate cancer	0.000251	0.00362	CcSEcCtD
Clevidipine—Acute coronary syndrome—Prednisone—prostate cancer	0.000247	0.00357	CcSEcCtD
Clevidipine—Myocardial infarction—Prednisone—prostate cancer	0.000246	0.00355	CcSEcCtD
Clevidipine—BCHE—lymph node—prostate cancer	0.000241	0.00993	CbGeAlD
Clevidipine—Dyspnoea—Mitoxantrone—prostate cancer	0.000239	0.00345	CcSEcCtD
Clevidipine—Vomiting—Goserelin—prostate cancer	0.000231	0.00333	CcSEcCtD
Clevidipine—Vomiting—Conjugated Estrogens—prostate cancer	0.000229	0.0033	CcSEcCtD
Clevidipine—Headache—Goserelin—prostate cancer	0.000227	0.00328	CcSEcCtD
Clevidipine—Headache—Conjugated Estrogens—prostate cancer	0.000225	0.00325	CcSEcCtD
Clevidipine—Nisoldipine—CYP3A5—prostate cancer	0.000223	0.0568	CrCbGaD
Clevidipine—CYP2D6—testis—prostate cancer	0.00022	0.00908	CbGeAlD
Clevidipine—Tachycardia—Etoposide—prostate cancer	0.000218	0.00314	CcSEcCtD
Clevidipine—Nimodipine—CYP3A5—prostate cancer	0.000216	0.0548	CrCbGaD
Clevidipine—Nausea—Goserelin—prostate cancer	0.000216	0.00311	CcSEcCtD
Clevidipine—Nausea—Conjugated Estrogens—prostate cancer	0.000214	0.00308	CcSEcCtD
Clevidipine—Hypersensitivity—Estradiol—prostate cancer	0.000212	0.00306	CcSEcCtD
Clevidipine—Nitrendipine—CYP3A5—prostate cancer	0.000209	0.0531	CrCbGaD
Clevidipine—Hypotension—Etoposide—prostate cancer	0.000208	0.00301	CcSEcCtD
Clevidipine—Nilvadipine—CYP2A6—prostate cancer	0.000202	0.0514	CrCbGaD
Clevidipine—Dyspnoea—Etoposide—prostate cancer	0.000199	0.00287	CcSEcCtD
Clevidipine—Hypersensitivity—Mitoxantrone—prostate cancer	0.000198	0.00285	CcSEcCtD
Clevidipine—Vomiting—Estradiol—prostate cancer	0.000183	0.00264	CcSEcCtD
Clevidipine—Tachycardia—Docetaxel—prostate cancer	0.000181	0.00261	CcSEcCtD
Clevidipine—Headache—Estradiol—prostate cancer	0.00018	0.0026	CcSEcCtD
Clevidipine—Amlodipine—CYP3A5—prostate cancer	0.00018	0.0457	CrCbGaD
Clevidipine—Tachycardia—Capecitabine—prostate cancer	0.000175	0.00253	CcSEcCtD
Clevidipine—Amlodipine—CYP2A6—prostate cancer	0.000174	0.0443	CrCbGaD
Clevidipine—Hypotension—Docetaxel—prostate cancer	0.000173	0.0025	CcSEcCtD
Clevidipine—Nausea—Estradiol—prostate cancer	0.000171	0.00247	CcSEcCtD
Clevidipine—Vomiting—Mitoxantrone—prostate cancer	0.00017	0.00246	CcSEcCtD
Clevidipine—Headache—Mitoxantrone—prostate cancer	0.000168	0.00243	CcSEcCtD
Clevidipine—Hypotension—Capecitabine—prostate cancer	0.000168	0.00242	CcSEcCtD
Clevidipine—Felodipine—CYP3A5—prostate cancer	0.000166	0.0423	CrCbGaD
Clevidipine—Dyspnoea—Docetaxel—prostate cancer	0.000165	0.00239	CcSEcCtD
Clevidipine—Hypersensitivity—Etoposide—prostate cancer	0.000164	0.00237	CcSEcCtD
Clevidipine—Nifedipine—CYP3A5—prostate cancer	0.000161	0.0409	CrCbGaD
Clevidipine—Dyspnoea—Capecitabine—prostate cancer	0.00016	0.00231	CcSEcCtD
Clevidipine—Nausea—Mitoxantrone—prostate cancer	0.000159	0.0023	CcSEcCtD
Clevidipine—Nicardipine—CYP3A5—prostate cancer	0.000158	0.0402	CrCbGaD
Clevidipine—Tachycardia—Prednisone—prostate cancer	0.000156	0.00225	CcSEcCtD
Clevidipine—Nifedipine—CYP2A6—prostate cancer	0.000156	0.0396	CrCbGaD
Clevidipine—Nilvadipine—CYP2E1—prostate cancer	0.000144	0.0365	CrCbGaD
Clevidipine—Nilvadipine—CYP2C19—prostate cancer	0.000142	0.0361	CrCbGaD
Clevidipine—Vomiting—Etoposide—prostate cancer	0.000142	0.00205	CcSEcCtD
Clevidipine—Headache—Etoposide—prostate cancer	0.00014	0.00202	CcSEcCtD
Clevidipine—Hypersensitivity—Docetaxel—prostate cancer	0.000137	0.00197	CcSEcCtD
Clevidipine—Nausea—Etoposide—prostate cancer	0.000132	0.00191	CcSEcCtD
Clevidipine—Hypersensitivity—Capecitabine—prostate cancer	0.000132	0.00191	CcSEcCtD
Clevidipine—Tachycardia—Epirubicin—prostate cancer	0.000122	0.00176	CcSEcCtD
Clevidipine—Amlodipine—CYP1A1—prostate cancer	0.000122	0.031	CrCbGaD
Clevidipine—Vomiting—Docetaxel—prostate cancer	0.000118	0.0017	CcSEcCtD
Clevidipine—Hypersensitivity—Prednisone—prostate cancer	0.000118	0.0017	CcSEcCtD
Clevidipine—Hypotension—Epirubicin—prostate cancer	0.000117	0.00169	CcSEcCtD
Clevidipine—Headache—Docetaxel—prostate cancer	0.000116	0.00168	CcSEcCtD
Clevidipine—Isradipine—CYP3A4—prostate cancer	0.000115	0.0291	CrCbGaD
Clevidipine—Vomiting—Capecitabine—prostate cancer	0.000114	0.00165	CcSEcCtD
Clevidipine—Tachycardia—Doxorubicin—prostate cancer	0.000113	0.00163	CcSEcCtD
Clevidipine—Headache—Capecitabine—prostate cancer	0.000112	0.00162	CcSEcCtD
Clevidipine—Dyspnoea—Epirubicin—prostate cancer	0.000111	0.00161	CcSEcCtD
Clevidipine—Nifedipine—CYP2E1—prostate cancer	0.000111	0.0281	CrCbGaD
Clevidipine—Nausea—Docetaxel—prostate cancer	0.00011	0.00159	CcSEcCtD
Clevidipine—Nifedipine—CYP1A1—prostate cancer	0.000109	0.0277	CrCbGaD
Clevidipine—Nicardipine—CYP2E1—prostate cancer	0.000109	0.0277	CrCbGaD
Clevidipine—Hypotension—Doxorubicin—prostate cancer	0.000108	0.00156	CcSEcCtD
Clevidipine—Nicardipine—CYP2C19—prostate cancer	0.000108	0.0274	CrCbGaD
Clevidipine—Nausea—Capecitabine—prostate cancer	0.000107	0.00154	CcSEcCtD
Clevidipine—Dyspnoea—Doxorubicin—prostate cancer	0.000103	0.00149	CcSEcCtD
Clevidipine—Vomiting—Prednisone—prostate cancer	0.000102	0.00147	CcSEcCtD
Clevidipine—Headache—Prednisone—prostate cancer	0.0001	0.00145	CcSEcCtD
Clevidipine—Nisoldipine—CYP3A4—prostate cancer	9.67e-05	0.0246	CrCbGaD
Clevidipine—Nausea—Prednisone—prostate cancer	9.5e-05	0.00137	CcSEcCtD
Clevidipine—Nimodipine—CYP3A4—prostate cancer	9.34e-05	0.0237	CrCbGaD
Clevidipine—Hypersensitivity—Epirubicin—prostate cancer	9.21e-05	0.00133	CcSEcCtD
Clevidipine—Nilvadipine—CYP3A4—prostate cancer	9.04e-05	0.023	CrCbGaD
Clevidipine—Nitrendipine—CYP3A4—prostate cancer	9.04e-05	0.023	CrCbGaD
Clevidipine—Hypersensitivity—Doxorubicin—prostate cancer	8.52e-05	0.00123	CcSEcCtD
Clevidipine—Vomiting—Epirubicin—prostate cancer	7.95e-05	0.00115	CcSEcCtD
Clevidipine—Headache—Epirubicin—prostate cancer	7.83e-05	0.00113	CcSEcCtD
Clevidipine—Amlodipine—CYP3A4—prostate cancer	7.79e-05	0.0198	CrCbGaD
Clevidipine—Nausea—Epirubicin—prostate cancer	7.43e-05	0.00107	CcSEcCtD
Clevidipine—Vomiting—Doxorubicin—prostate cancer	7.36e-05	0.00106	CcSEcCtD
Clevidipine—Headache—Doxorubicin—prostate cancer	7.25e-05	0.00105	CcSEcCtD
Clevidipine—Felodipine—CYP3A4—prostate cancer	7.2e-05	0.0183	CrCbGaD
Clevidipine—Nifedipine—CYP3A4—prostate cancer	6.96e-05	0.0177	CrCbGaD
Clevidipine—Nausea—Doxorubicin—prostate cancer	6.87e-05	0.000992	CcSEcCtD
Clevidipine—Nicardipine—CYP3A4—prostate cancer	6.85e-05	0.0174	CrCbGaD
Clevidipine—CYP3A4—Metabolism—HSD3B1—prostate cancer	3.41e-06	3.08e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—CYP17A1—prostate cancer	3.38e-06	3.06e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—SLC5A5—prostate cancer	3.37e-06	3.05e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	3.34e-06	3.02e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—NCOA3—prostate cancer	3.3e-06	2.98e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—CYP2E1—prostate cancer	3.29e-06	2.98e-05	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—TYMS—prostate cancer	3.27e-06	2.96e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—GSTA4—prostate cancer	3.27e-06	2.96e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—TBXAS1—prostate cancer	3.27e-06	2.96e-05	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—PIK3CD—prostate cancer	3.26e-06	2.95e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—NQO1—prostate cancer	3.26e-06	2.94e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—NCOA2—prostate cancer	3.25e-06	2.94e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	3.24e-06	2.93e-05	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—GSTM1—prostate cancer	3.24e-06	2.92e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—NCOA2—prostate cancer	3.22e-06	2.91e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—TH—prostate cancer	3.21e-06	2.9e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.19e-06	2.88e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—GSTA2—prostate cancer	3.19e-06	2.88e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—CYP3A4—prostate cancer	3.18e-06	2.87e-05	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—LPL—prostate cancer	3.18e-06	2.87e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.16e-06	2.86e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—HPGDS—prostate cancer	3.15e-06	2.85e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—SULT1A1—prostate cancer	3.15e-06	2.84e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—ABCG5—prostate cancer	3.15e-06	2.84e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—CYP2C19—prostate cancer	3.13e-06	2.83e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—CYP1B1—prostate cancer	3.12e-06	2.82e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—SLC5A5—prostate cancer	3.1e-06	2.8e-05	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—NOS3—prostate cancer	3.08e-06	2.78e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—SLC5A5—prostate cancer	3.08e-06	2.78e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—GSTA1—prostate cancer	3.07e-06	2.78e-05	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—CYP1A1—prostate cancer	3.07e-06	2.77e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—GSTT1—prostate cancer	3.05e-06	2.76e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—ACHE—prostate cancer	3.05e-06	2.76e-05	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—ERCC2—prostate cancer	3.04e-06	2.75e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—HSD3B2—prostate cancer	3.04e-06	2.75e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—GSTO1—prostate cancer	3.04e-06	2.75e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—NAT2—prostate cancer	3.04e-06	2.75e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—CYP2E1—prostate cancer	3.03e-06	2.74e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—GGT1—prostate cancer	3.02e-06	2.73e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—CYP2A6—prostate cancer	3.02e-06	2.73e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	3.01e-06	2.72e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—CYP2E1—prostate cancer	3e-06	2.71e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—NQO1—prostate cancer	3e-06	2.71e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—NCOA1—prostate cancer	2.98e-06	2.69e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—NQO1—prostate cancer	2.97e-06	2.68e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—TH—prostate cancer	2.95e-06	2.67e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—AKR1C3—prostate cancer	2.94e-06	2.65e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—CYP19A1—prostate cancer	2.94e-06	2.65e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—TH—prostate cancer	2.93e-06	2.65e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—CYP3A4—prostate cancer	2.92e-06	2.64e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—PRKACB—prostate cancer	2.92e-06	2.64e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—PLCB2—prostate cancer	2.91e-06	2.63e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—LRP2—prostate cancer	2.91e-06	2.63e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—CYP2C18—prostate cancer	2.91e-06	2.63e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.91e-06	2.63e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—CYP3A4—prostate cancer	2.9e-06	2.62e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—CYP17A1—prostate cancer	2.89e-06	2.61e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.88e-06	2.6e-05	CbGpPWpGaD
Clevidipine—CACNA1D—Metabolism—PIK3CA—prostate cancer	2.88e-06	2.6e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—CYP1B1—prostate cancer	2.87e-06	2.6e-05	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—MTHFR—prostate cancer	2.86e-06	2.58e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—P4HB—prostate cancer	2.86e-06	2.58e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.85e-06	2.58e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—CYP1B1—prostate cancer	2.85e-06	2.57e-05	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—PIK3CB—prostate cancer	2.84e-06	2.57e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—RXRA—prostate cancer	2.83e-06	2.56e-05	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—PTGS2—prostate cancer	2.82e-06	2.54e-05	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—PPARA—prostate cancer	2.81e-06	2.54e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—GGT1—prostate cancer	2.78e-06	2.51e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—SLC22A1—prostate cancer	2.78e-06	2.51e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—GGT1—prostate cancer	2.76e-06	2.49e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.76e-06	2.49e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—NCOA2—prostate cancer	2.75e-06	2.49e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—NCOA1—prostate cancer	2.74e-06	2.48e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—COMT—prostate cancer	2.73e-06	2.47e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—GSTP1—prostate cancer	2.72e-06	2.46e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—NCOA1—prostate cancer	2.72e-06	2.46e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—SULT2A1—prostate cancer	2.71e-06	2.45e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—CYP19A1—prostate cancer	2.7e-06	2.44e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—CYP19A1—prostate cancer	2.68e-06	2.42e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—ITPR1—prostate cancer	2.67e-06	2.42e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—MED12—prostate cancer	2.67e-06	2.41e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—GNG5—prostate cancer	2.64e-06	2.39e-05	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—CAV1—prostate cancer	2.64e-06	2.38e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.63e-06	2.38e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—SLC5A5—prostate cancer	2.63e-06	2.38e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—RXRA—prostate cancer	2.61e-06	2.36e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—RXRA—prostate cancer	2.58e-06	2.34e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—CYP2E1—prostate cancer	2.57e-06	2.32e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—NCOA3—prostate cancer	2.55e-06	2.3e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—NQO1—prostate cancer	2.54e-06	2.29e-05	CbGpPWpGaD
Clevidipine—CACNA1C—Metabolism—PIK3CA—prostate cancer	2.53e-06	2.29e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—TYMS—prostate cancer	2.53e-06	2.28e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.51e-06	2.27e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—COMT—prostate cancer	2.51e-06	2.27e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—TH—prostate cancer	2.5e-06	2.26e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—GSTP1—prostate cancer	2.5e-06	2.26e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—GSTM1—prostate cancer	2.5e-06	2.26e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—COMT—prostate cancer	2.49e-06	2.25e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.49e-06	2.25e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—GSTP1—prostate cancer	2.48e-06	2.24e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—CYP3A4—prostate cancer	2.47e-06	2.24e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.46e-06	2.23e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—ITPR1—prostate cancer	2.46e-06	2.22e-05	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—PTEN—prostate cancer	2.46e-06	2.22e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—LPL—prostate cancer	2.45e-06	2.21e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—ITPR1—prostate cancer	2.44e-06	2.2e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—CYP1B1—prostate cancer	2.43e-06	2.2e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—HPGDS—prostate cancer	2.43e-06	2.2e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—CYP2C19—prostate cancer	2.41e-06	2.18e-05	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—PIK3CG—prostate cancer	2.4e-06	2.17e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.4e-06	2.17e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—CYP1A1—prostate cancer	2.37e-06	2.14e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—ACHE—prostate cancer	2.36e-06	2.13e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—GSTT1—prostate cancer	2.36e-06	2.13e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—GGT1—prostate cancer	2.36e-06	2.13e-05	CbGpPWpGaD
Clevidipine—CACNA1D—Metabolism—AKT1—prostate cancer	2.35e-06	2.13e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—ERCC2—prostate cancer	2.35e-06	2.12e-05	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—EP300—prostate cancer	2.34e-06	2.12e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—CYP2A6—prostate cancer	2.33e-06	2.11e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—TYMS—prostate cancer	2.32e-06	2.1e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—NCOA1—prostate cancer	2.32e-06	2.1e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—TYMS—prostate cancer	2.3e-06	2.08e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—GSTM1—prostate cancer	2.3e-06	2.08e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—CYP19A1—prostate cancer	2.29e-06	2.07e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—GSTM1—prostate cancer	2.28e-06	2.06e-05	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—INS—prostate cancer	2.27e-06	2.06e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—AKR1C3—prostate cancer	2.27e-06	2.05e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—PRKACB—prostate cancer	2.25e-06	2.04e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—LPL—prostate cancer	2.25e-06	2.04e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—LPL—prostate cancer	2.23e-06	2.02e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—CYP17A1—prostate cancer	2.23e-06	2.02e-05	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—CREBBP—prostate cancer	2.23e-06	2.01e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—RXRA—prostate cancer	2.21e-06	2e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—MTHFR—prostate cancer	2.21e-06	1.99e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—CYP1A1—prostate cancer	2.18e-06	1.97e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—PPARA—prostate cancer	2.16e-06	1.96e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—ERCC2—prostate cancer	2.16e-06	1.95e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—CYP1A1—prostate cancer	2.16e-06	1.95e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.15e-06	1.94e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—ERCC2—prostate cancer	2.14e-06	1.93e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—COMT—prostate cancer	2.13e-06	1.92e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—NCOA2—prostate cancer	2.13e-06	1.92e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—GSTP1—prostate cancer	2.12e-06	1.91e-05	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—PIK3CD—prostate cancer	2.11e-06	1.91e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—ITPR1—prostate cancer	2.08e-06	1.88e-05	CbGpPWpGaD
Clevidipine—CACNA1C—Metabolism—AKT1—prostate cancer	2.07e-06	1.87e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.05e-06	1.85e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—CAV1—prostate cancer	2.04e-06	1.84e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—MTHFR—prostate cancer	2.03e-06	1.83e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—SLC5A5—prostate cancer	2.03e-06	1.83e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—MTHFR—prostate cancer	2.01e-06	1.82e-05	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—NOS3—prostate cancer	1.99e-06	1.8e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—PPARA—prostate cancer	1.99e-06	1.8e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.98e-06	1.79e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—PPARA—prostate cancer	1.97e-06	1.78e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—TYMS—prostate cancer	1.97e-06	1.78e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—NQO1—prostate cancer	1.96e-06	1.77e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—GSTM1—prostate cancer	1.95e-06	1.76e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.94e-06	1.76e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—TH—prostate cancer	1.93e-06	1.74e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—LPL—prostate cancer	1.91e-06	1.73e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.88e-06	1.7e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—CAV1—prostate cancer	1.87e-06	1.69e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—CAV1—prostate cancer	1.86e-06	1.68e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—PIK3CG—prostate cancer	1.85e-06	1.68e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—CYP1A1—prostate cancer	1.84e-06	1.67e-05	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—PIK3CB—prostate cancer	1.84e-06	1.66e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—ERCC2—prostate cancer	1.83e-06	1.65e-05	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—PTGS2—prostate cancer	1.82e-06	1.65e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—GGT1—prostate cancer	1.82e-06	1.64e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—NCOA1—prostate cancer	1.79e-06	1.62e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.77e-06	1.6e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.77e-06	1.6e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—INS—prostate cancer	1.75e-06	1.59e-05	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—PIK3CA—prostate cancer	1.73e-06	1.57e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—MTHFR—prostate cancer	1.72e-06	1.55e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—CREBBP—prostate cancer	1.72e-06	1.55e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—PIK3CG—prostate cancer	1.7e-06	1.54e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—RXRA—prostate cancer	1.7e-06	1.54e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—PIK3CG—prostate cancer	1.69e-06	1.53e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—PPARA—prostate cancer	1.69e-06	1.52e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—COMT—prostate cancer	1.64e-06	1.48e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—GSTP1—prostate cancer	1.63e-06	1.48e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—PIK3CD—prostate cancer	1.63e-06	1.47e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—INS—prostate cancer	1.61e-06	1.46e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—ITPR1—prostate cancer	1.61e-06	1.45e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—INS—prostate cancer	1.6e-06	1.45e-05	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—PTEN—prostate cancer	1.59e-06	1.44e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—CAV1—prostate cancer	1.59e-06	1.43e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—CREBBP—prostate cancer	1.58e-06	1.43e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—CREBBP—prostate cancer	1.57e-06	1.42e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—NOS3—prostate cancer	1.54e-06	1.39e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—TYMS—prostate cancer	1.52e-06	1.37e-05	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—EP300—prostate cancer	1.52e-06	1.37e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.51e-06	1.37e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—GSTM1—prostate cancer	1.5e-06	1.36e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—PIK3CD—prostate cancer	1.5e-06	1.35e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—PIK3CD—prostate cancer	1.49e-06	1.34e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—LPL—prostate cancer	1.47e-06	1.33e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—PIK3CG—prostate cancer	1.44e-06	1.31e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.42e-06	1.29e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—PIK3CB—prostate cancer	1.42e-06	1.28e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—NOS3—prostate cancer	1.42e-06	1.28e-05	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—AKT1—prostate cancer	1.42e-06	1.28e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—ERCC2—prostate cancer	1.41e-06	1.28e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—PTGS2—prostate cancer	1.41e-06	1.27e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—NOS3—prostate cancer	1.4e-06	1.27e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—INS—prostate cancer	1.37e-06	1.24e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—CREBBP—prostate cancer	1.34e-06	1.21e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—MTHFR—prostate cancer	1.33e-06	1.2e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—PIK3CB—prostate cancer	1.31e-06	1.18e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—PPARA—prostate cancer	1.3e-06	1.18e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—PIK3CB—prostate cancer	1.3e-06	1.17e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—PTGS2—prostate cancer	1.29e-06	1.17e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—PTGS2—prostate cancer	1.28e-06	1.16e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—PIK3CD—prostate cancer	1.27e-06	1.15e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—PTEN—prostate cancer	1.23e-06	1.11e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—CAV1—prostate cancer	1.22e-06	1.11e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—NOS3—prostate cancer	1.2e-06	1.08e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—EP300—prostate cancer	1.17e-06	1.06e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—PTEN—prostate cancer	1.13e-06	1.02e-05	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—PIK3CA—prostate cancer	1.12e-06	1.01e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—PTEN—prostate cancer	1.12e-06	1.01e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.11e-06	1.01e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—PIK3CB—prostate cancer	1.11e-06	1e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—PTGS2—prostate cancer	1.1e-06	9.91e-06	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—EP300—prostate cancer	1.08e-06	9.73e-06	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—EP300—prostate cancer	1.07e-06	9.65e-06	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—INS—prostate cancer	1.06e-06	9.54e-06	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—CREBBP—prostate cancer	1.03e-06	9.34e-06	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—PIK3CD—prostate cancer	9.8e-07	8.86e-06	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—PTEN—prostate cancer	9.56e-07	8.64e-06	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—NOS3—prostate cancer	9.25e-07	8.36e-06	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—AKT1—prostate cancer	9.17e-07	8.29e-06	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—EP300—prostate cancer	9.12e-07	8.24e-06	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—PIK3CA—prostate cancer	8.66e-07	7.83e-06	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—PIK3CB—prostate cancer	8.54e-07	7.72e-06	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—PTGS2—prostate cancer	8.46e-07	7.65e-06	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—PIK3CA—prostate cancer	7.96e-07	7.2e-06	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—PIK3CA—prostate cancer	7.9e-07	7.14e-06	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—PTEN—prostate cancer	7.38e-07	6.67e-06	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—AKT1—prostate cancer	7.07e-07	6.39e-06	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—EP300—prostate cancer	7.04e-07	6.36e-06	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—PIK3CA—prostate cancer	6.75e-07	6.1e-06	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—AKT1—prostate cancer	6.51e-07	5.88e-06	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—AKT1—prostate cancer	6.45e-07	5.83e-06	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—AKT1—prostate cancer	5.51e-07	4.98e-06	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—PIK3CA—prostate cancer	5.21e-07	4.71e-06	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—AKT1—prostate cancer	4.25e-07	3.84e-06	CbGpPWpGaD
